| Document |
Document Title |
|
WO/2001/009082A1 |
The invention relates to a process for preparing an esterquat composition comprising (a) reacting a tertiary amine according to formula (I) wherein R?1¿ represents a C¿3?-C¿6? hydrocarbon group, R?2¿ represents a C¿3?-C¿6? hydrocar...
|
|
WO/2000/078846A1 |
Degradable cross-linkers which are used to form polymer networks which degrade under aqueous conditions are described. These cross-linkers comprise a monodispersed central polyacid, monodispersed monomeric or monodispersed oligomeric deg...
|
|
WO/2000/073257A1 |
The present invention provides a series of compounds having structural formulas (I), (II), (III), (IV) wherein n¿1? is 1 to 5, n¿2? is 1 to 4 and m is 1 to 3; X is O or NH; Y is CH2, O, S, NH, NR; R is selected from the group consistin...
|
|
WO/2000/069806A1 |
The invention relates to amines of general formula (I) or to the mirror image thereof, wherein R?1¿ means hydrogen, C¿1-6?-alkyl, aryl-C¿1-4?-alkyl or acyl. The inventive amines are produced by means of steteroselective hydrogenation ...
|
|
WO/2000/066528A2 |
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.
|
|
WO/2000/061537A2 |
Compounds or their salts having general formulas (I) and (II): wherein s is and integer equal to 1 or 2, preferably s = 2; A is the radical of a drug and is such as to meet the pharmacological tests reported in the description, C and C¿...
|
|
WO/2000/061549A2 |
Compounds or their salts of general formula (I): A-(B) wherein A = R-T¿1?-, wherein R is the drug radical and T¿1? = (CO)¿t? or (X)¿t'?, wherein X = O, S, NR¿1C?, R¿1C? is H or an alkyl having from 1 to 5 carbon atoms, or a free va...
|
|
WO/2000/061541A2 |
Compounds or their salts having general formulas (I) and (II) wherein: s = is an integer equal to 1 or 2, preferably s = 2; b0 = 0 or 1; A is the radical of a drug and is such as to meet the pharmacological tests reported in the descript...
|
|
WO/2000/056700A1 |
An ionic liquid having a melting point of no more than 60 °C, formed by the reaction of a quaternary ammonium compound of formula R?1¿ R?2¿ R?3¿ R?4¿ N?+¿ X?-¿ (I) or a mixture of two or more thereof; with a halide of zinc, tin or...
|
|
WO/2000/053570A1 |
Esterquats, their intermediates, a process to make the esterquats, and their use as a fabric softener wherein said esterquats are of the formula: R¿4?[R¿5?R¿6?N?+¿Z]¿n? X?-¿, wherein Z is covalently bonded to the nitrogen atom and ...
|
|
WO1996012697A9 |
The present invention features compounds of general formulae a), b), c), able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. P...
|
|
WO/2000/043347A1 |
The invention concerns a method for making aqueous solutions of unsaturated quaternary ammonium salts of formula (I) by reacting, in the presence of water, N,N-dimethylaminoethyl acrylate with a quaternizing agent of formula (II): R - Cl...
|
|
WO/2000/043346A1 |
The invention concerns a method for making aqueous solutions of unsaturated quaternary ammonium salts of formula (I) by reacting, in the presence of water, N,N-dimethylaminoethyl acrylate with a quaternizing agent of formula (II): R-Cl. ...
|
|
WO/2000/043348A1 |
The invention concerns a method for making an aqueous solution of unsaturated quaternary ammonium salts of formula (I), by reacting, in the presence of water, N,N-dimethylaminoethyl acrylate with a quaternizing agent of formula (II):R-Cl...
|
|
WO/2000/039241A1 |
A compound of general formula (I), (II), or (III): wherein each of R¿1? through R¿20? are independently selected from straight or branched chain, substituted or unsubstituted C¿1?-C¿22? alkyl or alkenyl groups, wherein said alkyl or ...
|
|
WO/2000/034232A1 |
Serine carbonates of formula I are precursors for organoleptic compounds, masking agents and antimicrobial agents. Further they are alternative substrates for malodor producing enzymes. The symbols in formula I are defined in claim 1.
|
|
WO2000012454A9 |
A cationic lipid for transfection of macromolecules in which the lipid has a polyether or glyceryl backbone which lipids can be contained in a liposome to effectively transfect a variety of cell types and improve the efficiency of transf...
|
|
WO/2000/032560A1 |
A composition for use in protecting or improving a skin which comprises a polymer having a structure represented by formula (9), wherein each of R1, R2 and R3 independently represents a hydrogen atom, or an alkyl, an alkyloxy or an alkyl...
|
|
WO/2000/032559A1 |
A class of cationic ester surfactants is described which has improved hydrolytic stability. In particular, the present invention relates to the use of quaternized alkanol amine ester compositions wherein the ester is based on a secondary...
|
|
WO/2000/030444A1 |
The present invention relates to synthetic cationic lipids, liposome formulations and the use of such compounds to introduce functional bioactive agents into cultured cells.
|
|
WO/2000/027799A1 |
New esters derived from substituted phenyl-cyclohexyl compounds, derived from tramadol, process for obtaining such esters and use of said compounds for the fabrication of a medicament having analgesic properties. These new products havin...
|
|
WO/2000/023414A2 |
A process for the preparation of optically active cyclohexylglycolate esters is described. The process utilizes carboxylic acid activation to couple $i((R))- or $i((S))-cyclohexylphenylglycolic acid (CHPGA) with 4-$i(N,N)-diethylamino bu...
|
|
WO/2000/018724A1 |
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, ...
|
|
WO/2000/018721A1 |
The invention relates to substituted polycyclic aryl and heteroaryl $i(tertiary)-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions an...
|
|
WO/2000/017152A1 |
Amine derivatives represented by general formula (1) and preparations for external use containing the same which exhibit excellent effects of preventing the skin from aging, etc. In formula (1), R?1¿ represents C¿1-30? hydrocarbyl opti...
|
|
WO/2000/011041A1 |
The invention relates to a composition comprising a) at least one ethylenically unsaturated monomer or oligomer, b) a radical initiator which forms a radical upon heating or upon irradiation with (UV) light from 305 nm to 450 nm and c) a...
|
|
WO/2000/007981A1 |
The invention relates to a compound of formula (Ia), (Ib) or (Ic). The open chain alkoxyamine compounds are useful for the polymerization of ethylenically unsaturated monomers. The compounds of the present invention provide polymeric res...
|
|
WO/2000/006137A2 |
Compounds having Formula (I) are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of treating immune, autoimmune, inflammatory, ...
|
|
WO/2000/006679A1 |
The present invention relates to a method for preparing a cationic surfactant in which physical chemical characteristics such as softness, antistatic properties, etc. as well as biodegradability are quite excellent due to having an ester...
|
|
WO/2000/003580A2 |
The invention relates to the partially known 3,3-dichloro-2-fluoro-acrylic acid derivatives of formula (I), wherein A has the meanings mentioned in the description. Said substances are suitable for protecting plants against the attack of...
|
|
WO/1999/058478A1 |
The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the inv...
|
|
WO/1999/058492A1 |
The invention relates to quaternary ester compounds which have an ethoxylated hydroxycarboxylic acid as their basic framework. These cationic tensides are suitable for the production of water-white formulations, such as in particular hai...
|
|
WO/1999/053242A1 |
Disclosed are highly efficient multiphoton absorbing compounds and methods of their use. The compounds generally include a bridge of pi-conjugated bonds connecting electron donating groups or electron accepting groups. The bridge may be ...
|
|
WO/1999/051564A1 |
This invention relates to new propanolamine derivatives or salts thereof represented by general formula (I), wherein each symbol is as defined in the specification or salts thereof which are $g(b)¿3? adrergenic receptor agonists and the...
|
|
WO/1999/051662A1 |
Novel polyimide compositions having a cinnamic acid or cinnamic acid derivative skeleton and possessing both the photoreactivity and heat reactivity characteristic to the cinnamic acid skeleton. Novel diamines and acid dianhydrides, whic...
|
|
WO/1999/048857A1 |
The invention concerns anti-tumour agents of formula (I) wherein each of R?1¿, R?2¿ and R?3¿ has the meanings defined in the specification including hydrogen, (1-4C)alkyl, (3-4C)alkenyl, (3-4C)alkynyl, amino, (1-4C)alkylamino and (1-4...
|
|
WO/1999/038477A1 |
The invention relates to a method for permanently deforming keratin fibers in which the fibers are treated with an aqueous preparation of a keratin reducing substance before and/or after a mechanical deforming process. The fibers are sub...
|
|
WO/1999/036167A1 |
Cationic surfactants derived from amine derivatives of hexose alcohols which are reducing sugars of glucose or reducing alcohols of hexoses. These surfactants are obtained by converting 1-amino-hexose alcohols into quaternary salts and t...
|
|
WO/1999/035120A1 |
A quaternary ammonium compound selected from the group consisting of compounds of general formula (I), and general formula (II) wherein R is -H, -CH¿3? or -C¿2?H¿5?; R?1¿, R?2¿, and R?3¿ are each independently of one another fatty ...
|
|
WO/1999/035223A1 |
A quaternary ammonium compound selected from the group consisting of compounds of general formula (I) and general formula (II) wherein R is -H, -CH¿3? or -C¿2?H¿5?; R?1¿, R?2¿, and R?3¿ are each independently of one another fatty a...
|
|
WO/1999/033493A1 |
The present invention relates to new polyamide oligomers. These oligomers can be conjugated to lipids, nucleic acids, peptides, proteins, $i(etc). The oligomer-lipid conjugates can be used to form liposomes, virusomes, micelles, $i(etc.)...
|
|
WO/1999/029811A1 |
According to the inventive method for defoaming fuels, an effective quantity of at least one compound of formula (I) is added to the fuel. The radicals R?1¿, R?2¿ and R?3¿ in said formula represent an alkyl or hydroxyalkyl radical wit...
|
|
WO/1999/029283A2 |
The invention relates to the utilization of detergent mixtures containing (a) ester quaternaries which can be obtained by the condensation of fatty acids with alkanolamines and subsequent quaternization of the alkanolamine oligo-ester, a...
|
|
WO/1999/027783A1 |
Fungicidal compositions and methods comprising acylated aminosalicylamides (AASA) described herein. Novel cyclic amines and 3-nitrosalicylamides, and their use as pesticides and in the preparation of the antifungal AASA compounds are als...
|
|
WO/1999/020667A1 |
A novel high-performance polymer which is usable as a polymeric coagulant in centrifugal drying, belt-press drying, or the like and can attain a satisfactory dewatering rate. The polymer is a water-soluble vinyl polymer (A) which contain...
|
|
WO/1999/012890A1 |
Sphingosine derivatives capable of regulating the function of sphingolipids. The sphingosine derivatives are represented by general formula (I) wherein R?1¿ and R?2¿ are the same or different and each represents hydrogen, C¿1-4? alkyl...
|
|
WO/1999/013197A1 |
A method is disclosed for inhibiting the plugging of a conduit for the transport of hydrocarbon fluids by gas hydrates, wherein use is made of a hydrate formation inhibitor component of formula (I): (R¿1?) (R¿2?) (R¿3?) (R¿4?) A?+¿Y...
|
|
WO/1999/011258A1 |
The present invention relates to compounds which bind to all or parts of the active binding 'south pole pocket' of the LFA-1 I-domain and their uses as LFA-1 antagonists.
|
|
WO/1999/008997A1 |
The invention relates to novel lipopolyamines (including their salts), characterised by a symmetrical, highly flexible lipophilic component with a buffering capacity at physiological pH, and to their use for funnelling biologically activ...
|
|
WO/1999/001417A1 |
The present invention provides optically pure (S) 2-methylamino-2-phenyl-$i(n)-butyl 3,4,5-trimethoxybenzoate for use in the treatment of chronic pain, and having Formula (I). The present invention also provides methods of using the comp...
|
